Clinical Trials for Blastic Plasmacytoid Dendritic Cell Neoplasm

Find clinical trials for blastic plasmacytoid dendritic cell neoplasm. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

NCT ID: NCT06013423

This clinical trial is investigating a new treatment approach for patients with serious blood cancers, like acute leukemia and certain lymphomas. The study is testing how effective a transplant usi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

NCT ID: NCT03113643

This clinical trial is investigating a new treatment combination for patients with certain blood cancers, specifically Acute Myeloid Leukemia (AML), high-risk Myelodysplastic Syndrome (MDS), and Bl...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Duarte, California, United States +1 more

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT ID: NCT05362773

This clinical trial is studying a new treatment called MGD024 for patients with specific types of blood cancers that haven’t responded to standard treatments or have come back after treatment. The ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Durham, North Carolina, United States, Saint Louis, Missouri, United States +6 more

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT ID: NCT04216524

This clinical trial is exploring a new treatment approach for a rare type of cancer called blastic plasmacytoid dendritic cell neoplasm (BPDCN). The study is testing how well three treatments work ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

NCT ID: NCT03779854

This clinical trial is looking at a new way to help prevent a condition called chronic graft-versus-host disease (GVHD) in children and young adults with certain types of blood cancers, such as leu...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cleveland, Ohio, United States, Iowa City, Iowa, United States +10 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions